Olanzapine For MEC
Aug 15, 2024•14 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
A mixed bag of Phase III results for using olanzapine with moderately emegotenic chemotherapy (MEC).
Inui, et al: https://doi.org/10.1200/JCO.24.00278
Ostwal, et al: doi:10.1001/jamanetworkopen.2024.26076
For the best experience, listen in Metacast app for iOS or Android